Cannabis Use Disorders Identification Test

The Cannabis Use Disorders Identification Test (CUDIT) is a validated 10-item measure developed to identify problematic cannabis use, dependence symptoms, and related functional impairment. Adapted directly from the widely used AUDIT, the CUDIT focuses specifically on the past six months, providing a clear window into current usage patterns. For mental health clinicians, this instrument goes beyond simple frequency counts to systematically probe the behavioral and cognitive impact of cannabis consumption.

In clinical practice, distinguishing between recreational use and a developing use disorder can be challenging. The CUDIT addresses this by structuring the assessment around three core clinical domains: raw consumption metrics, signs of psychological dependence, and concrete psychosocial problems. This helps clinicians identify when cannabis use transitions into a maladaptive coping strategy that requires dedicated intervention.

Administering the CUDIT offers a highly reliable method for opening conversations about substance use without immediate confrontation. By capturing a standardized, repeatable score, clinicians can map the severity of the patient's presentation, track fluctuations in use over time, and evaluate the efficacy of harm-reduction or building new habits over the course of therapy.

The CUDIT measures the severity of problematic cannabis consumption by evaluating three distinct clinical dimensions over the preceding six months. It maps how usage patterns translate into functional impairment and dependence.

• Consumption patterns: The frequency of use, the typical duration of intoxication, and instances of prolonged use.
• Dependence symptoms: Loss of control over consumption (inability to stop) and using cannabis early in the day to counter the after-effects of previous use, often operating as entrenched automatic behaviors.
• Use-related problems: Functional consequences including neglected responsibilities, memory or concentration issues, feelings of guilt, physical injury, and external concern from family or medical professionals.

This instrument is intended for use with adults and adolescents who have reported any cannabis use within the last six months.

Clinicians typically integrate the CUDIT into their assessment when a patient discloses cannabis use, or when substance-induced symptoms are suspected.

• Intake and baseline assessment: To systematically document the severity of cannabis use and identify hidden functional impacts early in care, especially when assessing for bipolar disorder warning signs or acute mood shifts.
• Monitoring treatment progress: To track changes in consumption frequency and use-related problems over the course of harm-reduction or cessation therapy.
• Differential diagnosis: To help distinguish whether symptoms like low motivation, memory issues, or task initiation problems commonly seen in ADHD management are primary mental health concerns or secondary to heavy cannabis use.
• Facilitating motivational interviewing: To use the patient’s own item responses to build discrepancy and explore their ambivalence about change.

A validated CUDIT score provides an objective, standardized metric of severity that prevents clinicians from underestimating or overestimating the impact of a patient's cannabis use based on unstructured clinical impressions.